NCT05933980View on ClinicalTrials.gov

Toripalimab,Celecoxib and Regorafenib in the Treatment of Refractory Advanced Colorectal Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

December 19, 2023

Primary Completion Date

September 20, 2025

Study Completion Date

December 20, 2025

Conditions
Colorectal CancerLiver MetastasesMSS
Interventions
DRUG

Rego+Tori+Cele

combination of Toripalimab,regorafenib and celecoxib

Trial Locations (1)

510655

RECRUITING

Gastrointestinal Hospital, Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER